FDA OK's Onyx for brain vascular disorder
This article was originally published in Clinica
Executive Summary
The FDA has approved for sale in the US Micro Therapeutics' Onyx liquid embolic system for the treatment of arteriovenous malformations (AVMs), a vascular disorder in the brain. The Irvine, California firm will run a controlled introduction of Onyx in the US through its direct sales force.